Authors:
MORELAND IW
SCHIFF MH
BAUMGARTNER SW
TINDALL EA
FLEISCHMANN RM
BULPITT KJ
WEAVER A
KEYSTONE EC
WEINBLATT ME
FURST D
MEASE P
RUDERMAN E
ARKFELD DG
BLESCH CM
Citation: Iw. Moreland et al., PHASE-III TRIAL OF DMARD FAILING RHEUMATOID-ARTHRITIS PATIENTS WITH TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC, ENBREL(TM)), Journal of investigative medicine, 46(3), 1998, pp. 228-228
Authors:
MORELAND LW
BAUMGARTNER SW
TINDALL EA
SCHIFF MH
FLEISCHMANN RM
WEAVER A
MEASE P
RUDERMAN E
ETTLINGER R
GRUBER BL
LIES RB
BLOSCH CM
Citation: Lw. Moreland et al., LONG-TERM TREATMENT OF DMARD FAILING RHEUMATOID-ARTHRITIS PATIENTS WITH TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC ENBREL(TM)), Journal of investigative medicine, 46(3), 1998, pp. 229-229
Authors:
BOCANEGRA TS
WEAVER AL
TINDALL EA
SIKES DH
BALL JA
WALLEMARK CB
GEIS GS
FORT JG
Citation: Ts. Bocanegra et al., DICLOFENAC MISOPROSTOL COMPARED WITH DICLOFENAC IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE OR HIP - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL/, Journal of rheumatology, 25(8), 1998, pp. 1602-1611
Authors:
MORELAND LW
BAUMGARTNER SW
SCHIFF MH
TINDALL EA
FLEISCHMANN RM
WEAVER AL
BULPITT KJ
WEINBLATT ME
KEYSTONE EC
ETTINGER RE
FURST D
MEASE P
GRUBER BL
KATZ RS
SKOSEY JL
ARKFELD DG
LIES RB
LANGE M
BLOSCH CM
GARRISON L
Citation: Lw. Moreland et al., OPTIMAL DOSE OF TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC, ENBREL(TM)), Arthritis and rheumatism, 41(9), 1998, pp. 157-157
Authors:
BAUMGARTNER SW
MORELAND LW
SCHIFF MH
TINDALL EA
FLEISCHMANN RM
BULPITT KJ
WEAVER AL
KEYSTONE EC
WEINBLATT ME
FURST D
MEASE P
RUDERMAN EM
ARKFELD DG
LANGE M
GARRISON L
Citation: Sw. Baumgartner et al., RESPONSE OF ELDERLY PATIENTS TO TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC, ENBREL(TM)), Arthritis and rheumatism, 41(9), 1998, pp. 160-160
Authors:
MORELAND LW
BAUMGARTNER SW
TINDALL EA
SCHIFF MH
FLEISCHMANN RM
WEAVER AL
MEASE P
RUDEERMAN EM
ETTLINGER RE
GRUBER BL
LIES RB
LANGE M
BURGE DJ
Citation: Lw. Moreland et al., LONG-TERM SAFETY AND EFFICACY OF TNF RECEPTOR (P75) FC FUSION PROTEIN(TNFR-FC, ENBREL(TM)) IN DMARD REFRACTORY RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 1987-1987
Authors:
MORELAND LW
BAUMGARTNER SW
SCHIFF MH
TINDALL EA
FLEISCHMANN RM
WEAVER AL
ETTLINGER RE
COHEN S
KOOPMAN WJ
MOHLER K
WIDMER MB
BLOSCH CM
Citation: Lw. Moreland et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH A RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR RECEPTOR (P75)-FC FUSION PROTEIN, The New England journal of medicine, 337(3), 1997, pp. 141-147
Authors:
HOCHBERG MC
PRASHKER MJ
GREENWALD M
HANNAN MT
LANE NE
LINDSEY SM
LOVELL DJ
TINDALL EA
Citation: Mc. Hochberg et al., RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS, Arthritis and rheumatism, 39(11), 1996, pp. 1791-1801
Authors:
RASKIN JB
WHITE RH
JACKSON JE
WEAVER AL
TINDALL EA
LIES RB
STANTON DS
Citation: Jb. Raskin et al., MISOPROSTOL DOSAGE IN THE PREVENTION OF NONSTEROIDAL ANTIINFLAMMATORYDRUG-INDUCED GASTRIC AND DUODENAL-ULCERS - A COMPARISON OF 3 REGIMENS, Annals of internal medicine, 123(5), 1995, pp. 344-350
Authors:
ROTH SH
TINDALL EA
JAIN AK
MCMAHON FG
APRIL PA
BOCKOW BI
COHEN SB
FLEISCHMANN RM
Citation: Sh. Roth et al., A CONTROLLED-STUDY COMPARING THE EFFECTS OF NABUMETONE, IBUPROFEN, AND IBUPROFEN PLUS MISOPROSTOL ON THE UPPER GASTROINTESTINAL-TRACT MUCOSA, Archives of internal medicine, 153(22), 1993, pp. 2565-2571